Rome and ESC 2016

Rome and ESC 2016

Pope Francis at ESC Congress 2016.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Risikostratifizierung Für eine geeignete therapeutische Strategie zur kardiovaskulären Prävention werden in der aktuellen ESC/EAS-Leitlinie 4 Risikokategorien definiert. Risiko-modulierende Faktoren sind u. a. eine atherosklerotische kardiovaskuläre Erkrankung, ein bestehender Diabetes mellitus und ein bereits manifester Endorganschaden. LDL-C als primäres Therapieziel Das LDL-Cholesterin wird ...

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chairperson) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK), Volkmar Falk (Germany), José Ramón González-Juanatey (Spain), Veli-Pekka Harjola (Finland), Ewa A. Jankowska (Poland), Mariell Jessup (USA), Cecilia Linde (Sweden), Petros Ni...

Introduction. The Rome Foundation and Rome III.

It is a great pleasure to introduce the commentaries by Drs Kellow and Quigley on the pros and cons of the new Rome III criteria. Perhaps most of the readership is only familiar with these published diagnostic criteria. However, the Rome Foundation has a larger mission and directive to move the field of functional gastrointestinal (GI) and motility disorders forward through research and educati...